# Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients

> **NCT01837238** · NA · COMPLETED · sponsor: **University of Illinois at Urbana-Champaign** · enrollment: 41 (actual)

## Conditions studied

- Complication of Dialysis
- Chronic Kidney Disease
- Muscle Loss
- End Stage Renal Disease

## Interventions

- **DIETARY_SUPPLEMENT:** HMB
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT01837238
- **Lead sponsor:** University of Illinois at Urbana-Champaign
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2016-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01837238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01837238, "Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01837238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*